|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| ClinicalTrials.gov Identifier: | NCT00044434 |
Purpose
The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
| Condition | Intervention | Phase |
|---|---|---|
|
Alcoholism Smoking |
Drug: bupropion (Wellbutrin) |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study |
| Official Title: | Bupropion as a Smoking Cessation Aid in Alcoholics |
Eligibility| Ages Eligible for Study: | 25 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | NIAAAGRA13689 |
| Study First Received: | August 28, 2002 |
| Last Updated: | January 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00044434 History of Changes |
| Health Authority: | United States: Federal Government |
|
Dopamine Uptake Inhibitors Neurotransmitter Agents Psychotropic Drugs Disorders of Environmental Origin Smoking Dopamine Mental Disorders |
Alcoholism Bupropion Substance-Related Disorders Alcohol-Related Disorders Dopamine Agents Antidepressive Agents, Second-Generation Antidepressive Agents |
|
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Psychotropic Drugs Disorders of Environmental Origin Pharmacologic Actions Smoking Habits |
Mental Disorders Therapeutic Uses Alcoholism Bupropion Substance-Related Disorders Dopamine Agents Alcohol-Related Disorders Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |